AI assistant
ENTROPY NEURODYNAMICS LIMITED — Director's Dealing 2024
May 5, 2024
64855_rns_2024-05-05_e49c41b3-cdbd-41dd-8de8-43d0d3cd8082.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3X Initial Director’s Interest Notice
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.
| Name of entity | Tryptamine Therapeutics Limited (formerly Exopharm Limited) |
|---|---|
| ABN | 78 163 765 991 |
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Chris Ntoumenopoulos |
|---|---|
| Date of appointment | 1 May 2024 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
Nil
- See chapter 19 for defined terms.
Appendix 3X Page 1
11/3/2002
Appendix 3X Initial Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder & nature of interestNote: Provide details of the circumstances givingrise to the relevant interest.Sobol Capital Pty Ltd ATF Sobol CapitalTrust (Sole Director)Christopher Ntoumenopoulos & LeoNtoumenopoulos ATF TheNtoumenopoulos superannuation fund | Number & class of Securities5,000,000 – Ordinary Fully Paid Shares18,903,780 – Options @ $0.027 Exp 3 years from thedate of Reinstatement (escrowed for 24 months fromthe date of official quotation)2,892,8000 – Options @ $0.0531 Exp 5 years from thedate of Reinstatement (escrowed for 24 months fromthe date of official quotation)1,250,000 – Ordinary Fully Paid Shares |
|---|
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Nbe | Nbe | ote: In the case of a company, interests which come within paragrdisclosed in this part. | ote: In the case of a company, interests which come within paragrdisclosed in this part. | aph (ii) of the definitio | of notifiable interest | of a director should | of a director should | |
|---|---|---|---|---|---|---|---|---|
| Detail of contract | N/A | |||||||
| Nature of interest | N/A | |||||||
| Name of registered holder(if issued securities) | N/A | |||||||
| No. and class of securities to whichinterest relates | N/A |
- See chapter 19 for defined terms.
Appendix 3X Page 2
11/3/2002